Clinical Trials

Breast Neoplasms

NCT00903591 2026-06-03

Study of Radiation Exposure and Bilateral Breast Cancer

1,699 enrolled

Breast Neoplasms, Neoplasms

NCT06127979 2026-06-02

A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

42 enrolled

Breast Neoplasms

NCT06086704 2026-05-18

Study of 18F-FFNP Breast PET/MRI

Phase 2 Recruiting

53 enrolled

Breast Neoplasms

NCT02743858 2026-05-07

Lymphedema Surveillance Study

1,250 enrolled

Phase 1/2 Active not recruiting

Breast Neoplasms, Lymphedema

NCT04331067 2026-05-06

Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer

15 enrolled 12 charts

Triple Negative Breast Neoplasms

NCT07570524 2026-05-06

PRIME-TNBC

Not yet recruiting

200 enrolled

Phase NA Not yet recruiting

Triple Negative Breast Neoplasms

NCT07555600 2026-04-29

E-FACTOR

300 enrolled

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT07475923 2026-04-16

Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)

Withdrawn

Phase 1 Active not recruiting

Breast Neoplasms

NCT02453620 2026-04-13

Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer

57 enrolled

BreastOther solid neoplasm

Anatomic Stage III Breast Cancer AJCC v8

NCT05030038 2026-04-13

Oral Aromatase Inhibitors Modify the Gut Microbiome

25 enrolled

Phase 4 Not yet recruiting

Breast Neoplasms

NCT07490509 2026-04-01

DOSABEMA

235 enrolled

Phase 2 Active not recruiting

Breast Neoplasms

NCT04067726 2026-03-31

TRIDENT

210 enrolled

Breast Neoplasms

NCT05981326 2026-03-31

NEOEPICURE

300 enrolled

Breast Neoplasms

NCT06435546 2026-03-27

AdOTAC

200 enrolled

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT04068623 2026-03-20

PERCEPTION

90 enrolled

Triple Negative Breast Neoplasms

NCT05595577 2026-03-20

PALS

BreastGynecologicThoracic

110 enrolled

BreastLymphoid

Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT03987555 2026-03-18

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

Suspended

22 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulvar Neoplasms

NCT05964504 2026-03-17

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

12 enrolled

Breast Neoplasms, Carcinoma, Lobular

NCT07478016 2026-03-17

EXIST

200 enrolled

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00911911 2026-03-13

SPAM

66 enrolled

Breast Neoplasms

NCT03249389 2026-03-12

CALCIOBS

146 enrolled

Breast Neoplasms

NCT03252912 2026-03-12

LCS Bio Sein

51 enrolled

Phase 1/2 Active not recruiting

Breast Neoplasms

NCT04454528 2026-03-10

BreastVAX

27 enrolled

Breast Neoplasms

NCT01788839 2026-03-04

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

475 enrolled

BreastLymphoid

Breast Neoplasms, Coitus, Hodgkin Disease, Lymphoma

NCT06048835 2026-02-23

BioCellPhe

80 enrolled

Breast Neoplasms

NCT07421479 2026-02-19

PDO-Mercurial

50 enrolled

Triple Negative Breast Neoplasms

NCT02324062 2026-02-18

HCP

Completed

1,511 enrolled

BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

NCT01173341 2026-02-09

Cardiotoxicity of Cancer Therapy (CCT)

Enrolling by invitation

700 enrolled

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms

NCT07236177 2026-02-05

B-GLUCANCER2

220 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT03424915 2026-02-04

Exercise, Fitness and Tumor Profiling in Breast Cancer Patients

42 enrolled

Breast Neoplasms

NCT02338167 2026-01-30

PRAEGNANT

13,500 enrolled

Breast Neoplasms

NCT00897702 2026-01-28

Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast Cancer

Completed

269 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT04530890 2025-12-24

Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer

1,000 enrolled

BreastGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms

NCT07260188 2025-12-03

PDO-Neo01

240 enrolled

Triple Negative Breast Neoplasms

NCT06273800 2025-11-26

Chemosense

100 enrolled

Breast Neoplasms

NCT05798338 2025-11-25

Characterization of Extracellular Vesicles in Breast Cancer Patients

105 enrolled

Breast Neoplasms

NCT01349842 2025-11-24

CirCé01

Phase 3 Completed

265 enrolled

Phase NA Active not recruiting

Breast Cancer Ductal Infiltrating Metastatic

NCT03731845 2025-11-20

ESIGON

73 enrolled

BreastGynecologic

Breast Neoplasms, Primary Ovarian Insufficiency

NCT07084558 2025-10-28

TEODOR

350 enrolled

Breast Neoplasms

NCT00823654 2025-10-14

Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations

609 enrolled

Breast Neoplasms

NCT07124403 2025-09-17

DESIR

Not yet recruiting

742 enrolled

BreastGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms, Renal Insufficiency

NCT03758976 2025-09-16

Sweden Cancerome Analysis Network - Breast Recurrence (SCAN-B-rec)

2,000 enrolled

Breast Neoplasms, Neoplastic Cells, Circulating

NCT07010939 2025-09-12

PERSEVERE

3,000 enrolled

Breast Diseases, Breast Neoplasms

NCT02831634 2025-09-08

NeoEpitope

BreastGastrointestinalHead & Neck

25 enrolled

BreastDermatologic

Breast Neoplasms, Melanoma

NCT04042298 2025-09-02

Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy

Completed

62 enrolled

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms

NCT02743910 2025-07-17

Monitoring Plasma Tumor DNA in Early-Stage Breast Cancer

229 enrolled

Breast Neoplasms

NCT06896162 2025-07-11

PROGRESS

BreastGastrointestinalGenitourinaryThoracic

500 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT01953159 2025-06-08

Assessment of Paclitaxel-Induced Neuropathy